Europe

GSK's two-drug HIV regimen wins European panel approval
GSK's two-drug HIV regimen wins European panel approval
Reuters
GSK
HIV
Europe
CHMP
Juluca
Flag link:
EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017
EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017
RAPS.org
EMA
Europe
CHMP
FDA
Bevyxxa
Portola Pharmaceuticals
Dexxience
Tymlos
Radius Health
Eladynos
Flag link:
Teva takes issue with EC charges of pay-for-delay deal with Cephalon
Teva takes issue with EC charges of pay-for-delay deal with Cephalon
Seeking Alpha
Teva Pharmaceuticals
Europe
pay-for-delay
Cephalon
Provigil
generics
Flag link:
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
Businesswire
GSK
Europe
labeling
Relvar Ellipta
asthma
Flag link:
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Endpoints
Biogen
AbbVie
MS
multiple sclerosis
Zinbryta
Europe
encephalitis
Flag link:
Why Achillion Pharmaceuticals, Inc. Stock Spiked Monday
Why Achillion Pharmaceuticals, Inc. Stock Spiked Monday
Motley Fool
Achillion
Europe
kidney disease
ACH-4471
Flag link:
FDA Approves Drugs Before EMA and Swissmedic, Comparison Finds
FDA Approves Drugs Before EMA and Swissmedic, Comparison Finds
RAPS.org
FDA
EMA
Swissmedica
drug approvals
Europe
Switzerland
Flag link:
Novo Nordisk’s once-weekly Type II diabetes med approved in Europe
Novo Nordisk’s once-weekly Type II diabetes med approved in Europe
Drug Delivery Business News
Novo Nordisk
diabetes
type 2 diabetes
Europe
Ozempic
Flag link:
North of a billion biotech VC dollars to come from C-Bridge, Rothschild as global biopharma capital flows
North of a billion biotech VC dollars to come from C-Bridge, Rothschild as global biopharma capital flows
Endpoints
venture capital
biotech
C-Bridge
Rothschild
China
Europe
Flag link:
With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
Fierce Pharma
M&A
Sanofi
Europe
generics
Flag link:
GSK's shingles vaccine gets green light from EMA panel
GSK's shingles vaccine gets green light from EMA panel
Reuters
GSK
EMA
Europe
shingles
vaccines
Shingrix
Flag link:
EMA frets drug shortages ahead of Brexit
EMA frets drug shortages ahead of Brexit
Biopharma Dive
EMA
Europe
UK
drug shortages
Brexit
Flag link:
Puma Biotechnology shares tank after CHMP looks ready to hit a red light on neratinib
Puma Biotechnology shares tank after CHMP looks ready to hit a red light on neratinib
Endpoints
Puma Biotechnology
CHMP
neratinib
cancer
Europe
Flag link:
Shire's latest approval won't save it from Hemlibra
Shire's latest approval won't save it from Hemlibra
Biopharma Dive
Shire
Hemlibra
Adynovi
hemophilia
Europe
Adynovate
Flag link:
Roche granted approval for ocrelizumab (multiple sclerosis) in Europe
Roche granted approval for ocrelizumab (multiple sclerosis) in Europe
GoinPharma
Roche
ocrelizumab
Europe
MS
multiple sclerosis
Flag link:
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Fierce Pharma
Sanofi
Europe
generics
China
India
Flag link:
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Europe
AstraZeneca
Lynparza
ovarian cancer
Novo Nordisk
diabetes
semaglutide
Flag link:
As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report
As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report
Fierce Pharma
JNJ
biosimilars
Remicade
Europe
anti-TNF
Flag link:
EMA investigates Allergan blockbuster hopeful Esmya on reports of liver damage
EMA investigates Allergan blockbuster hopeful Esmya on reports of liver damage
Fierce Pharma
EMA
Allergan
Esmya
Europe
uterine fibroids
Flag link:
Europe’s medtech alliance seeks prompt action on new med device rules
Europe’s medtech alliance seeks prompt action on new med device rules
Mass Device
Europe
devices
Flag link:

Pages